Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drug Shortage Crisis Worsens

200-Plus Products Are In Short Supply In Most EU Countries

Executive Summary

As efforts continue to find ways of mitigating medicine shortages, a European survey has found not only that the situation is worsening, but that efforts to improve things are hindered by the patchwork of different rules on substitution and importation across the EU. 

You may also be interested in...



Belgian Law Seeks To Tackle Drug Shortages

Belgium is to impose new reporting obligations on pharmaceutical companies that become aware of drug supply interruptions, in a move that is seen by suppliers as less draconian than measures taken in other European countries

EU Drug Shortage Network Pilot Moves Into Second Phase

A single point of contact network that is expected to help EU countries share information on medicines shortages has completed its first phase and will be spread more widely this year.

EU Biosimilar Filings, Opinions And Approvals

A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS141621

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel